{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:57:02Z","timestamp":1778770622772,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15558-6","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:38:15Z","timestamp":1768207095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Establishing reference interval of serum CA-125 for the healthy Han population in China"],"prefix":"10.1186","volume":"26","author":[{"given":"Guo-Ming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"15558_CR1","doi-asserted-by":"crossref","unstructured":"Rao S, Smith DA, Guler E, Kikano EG, Rajdev MA, Yoest JM, et al. Past, Present, and future of serum tumor markers in management of ovarian cancer: A guide for the radiologist. Radiographics. 2021;41(6):1839\u201356.","DOI":"10.1148\/rg.2021210005"},{"issue":"4","key":"15558_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/172460089801300402","volume":"13","author":"RC Bast Jr","year":"1998","unstructured":"Bast RC Jr., Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB. CA 125: the past and the future. Int J Biol Markers. 1998;13(4):179\u201387.","journal-title":"Int J Biol Markers"},{"key":"15558_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2018.12.002","volume":"162","author":"M Hu","year":"2019","unstructured":"Hu M, Lan Y, Lu A, Ma X, Zhang L. Glycan-based biomarkers for diagnosis of cancers and other diseases: Past, present, and future. Prog Mol Biol Transl Sci. 2019;162:1\u201324.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"1","key":"15558_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s12885-024-12408-1","volume":"24","author":"Q Miao","year":"2024","unstructured":"Miao Q, Lei S, Chen F, Niu Q, Luo H, Cai B. A preliminary study on the reference intervals of serum tumor marker in apparently healthy elderly population in Southwestern China using real-world data. BMC Cancer. 2024;24(1):657.","journal-title":"BMC Cancer"},{"key":"15558_CR5","doi-asserted-by":"crossref","unstructured":"Yang J, Sa M, Huang M, Yang J, Xiang Z, Liu B, et al. The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay. Clin Biochem. 2013;46(16\u201317):1705\u20138.","DOI":"10.1016\/j.clinbiochem.2013.08.019"},{"issue":"5","key":"15558_CR6","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/ijc.26129","volume":"130","author":"Y Park","year":"2012","unstructured":"Park Y, Kim Y, Lee EY, Lee JH, Kim HS. Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer. Int J Cancer. 2012;130(5):1136\u201344.","journal-title":"Int J Cancer"},{"key":"15558_CR7","doi-asserted-by":"publisher","first-page":"e00353","DOI":"10.1016\/j.plabm.2023.e00353","volume":"38","author":"J Chen","year":"2024","unstructured":"Chen J, Fan L, Yang Z, Yang D. Comparison of results and age-related changes in Establishing reference intervals for CEA, AFP, CA125, and CA199 using four indirect methods. Pract Lab Med. 2024;38:e00353.","journal-title":"Pract Lab Med"},{"issue":"2","key":"15558_CR8","doi-asserted-by":"publisher","first-page":"e1107","DOI":"10.1002\/hsr2.1107","volume":"6","author":"EH Nah","year":"2023","unstructured":"Nah EH, Cho S, Park H, Kim S, Kwon E, Cho HI. Establishment and validation of reference intervals for tumor markers (AFP, CEA, CA19-9, CA15-3, CA125, PSA, HE4, Cyfra 21\u2009\u2013\u20091, and ProGRP) in primary care centers in korea: A cross-sectional retrospective study. Health Sci Rep. 2023;6(2):e1107.","journal-title":"Health Sci Rep"},{"key":"15558_CR9","doi-asserted-by":"crossref","unstructured":"Bjerner J, Hogetveit A, Wold Akselberg K, Vangsnes K, Paus E, Bjoro T, et al. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study. Scand J Clin Lab Invest. 2008;68(8):703\u201313.","DOI":"10.1080\/00365510802126836"},{"issue":"6","key":"15558_CR10","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1055\/s-0039-1683932","volume":"119","author":"GM Zhang","year":"2019","unstructured":"Zhang GM, Zhang W, Zhang GM. Age-Specific reference intervals for PT, aPTT, fibrinogen and thrombin time for parturient women. Thromb Haemost. 2019;119(6):894\u20138.","journal-title":"Thromb Haemost"},{"issue":"5","key":"15558_CR11","doi-asserted-by":"publisher","first-page":"e22380","DOI":"10.1002\/jcla.22380","volume":"32","author":"GM Zhang","year":"2018","unstructured":"Zhang GM, Bai SM, Zhang GM, Ma XB. Reference intervals of carbohydrate antigen 19\u2009\u2013\u20099 in the apparently healthy adult population. J Clin Lab Anal. 2018;32(5):e22380.","journal-title":"J Clin Lab Anal"},{"key":"15558_CR12","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.12659\/MSM.901861","volume":"22","author":"GM Zhang","year":"2016","unstructured":"Zhang GM, Guo XX, Ma XB, Zhang GM. Reference intervals of Alpha-Fetoprotein and carcinoembryonic antigen in the apparently healthy population. Med Sci Monit. 2016;22:4875\u201380.","journal-title":"Med Sci Monit"},{"key":"15558_CR13","doi-asserted-by":"crossref","unstructured":"Zhang GM, Xia YJ, Zhang GM, Zhu BL, Hu LY, Ma XB, et al. Laboratory reference intervals of complete blood count for apparently healthy elderly people in Shuyang, China. Clin Lab. 2014;60(12):2081\u20137.","DOI":"10.7754\/Clin.Lab.2014.140320"},{"issue":"6","key":"15558_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1080\/10408363.2023.2196746","volume":"60","author":"K Doyle","year":"2023","unstructured":"Doyle K, Bunch DR. Reference intervals: past, present, and future. Crit Rev Clin Lab Sci. 2023;60(6):466\u201382.","journal-title":"Crit Rev Clin Lab Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15558-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15558-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15558-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:35:42Z","timestamp":1770644142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15558-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15558"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15558-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shuyang Hospital (SYYYLL202424). When we collect blood samples, we inform patients whose blood samples may be used for scientific research activities. If you disagree, please let us know. By the time the paper was produced, we had not received any related requests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests. Patient consent for research: not applicable (retrospective study).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}